Does EVEROLIMUS Cause Hepatic function abnormal? 180 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 180 reports of Hepatic function abnormal have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.5% of all adverse event reports for EVEROLIMUS.
180
Reports of Hepatic function abnormal with EVEROLIMUS
0.5%
of all EVEROLIMUS reports
34
Deaths
76
Hospitalizations
How Dangerous Is Hepatic function abnormal From EVEROLIMUS?
Of the 180 reports, 34 (18.9%) resulted in death, 76 (42.2%) required hospitalization, and 20 (11.1%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 180 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which EVEROLIMUS Alternatives Have Lower Hepatic function abnormal Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE